HCL Tech is expected to be the growth leader among Tier I, with about 4.6-5.5 per cent sequential constant currency (CC) ...

HCL Technologies Q3 results are estimated to be strong with a revenue growth expected to be 4.5% on a sequential basis driven ...

HCL Tech will also declare a fourth interim dividend for the fiscal. Experts are forecasting an uptick in revenue and EBIT ...

HCL Technologies, India’s third-largest IT services company by market capitalization, is projected to report a year-on-year ...

For the upcoming quarter, HCL Technologies is expected to report a 4.4% growth in constant currency (CC) terms. The company's ...

In-line revenue, thanks to a seasonally strong quarter for HCL Software and a pick-up in ER&D; Positive surprise on margin on ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of ...

Included in the HCL deal are such IBM products as IBM Appscan, a security-focused application for identifying and managing vulnerabilities in mission-critical applications; IBM BigFix endpoint ...

HCL Technologies along with 13 other companies will be releasing its financial performance result for the quarter that ended ...

Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent ...

Darren Oberst, corporate vice president and head of the products and platforms business of HCL, told CRN that the acquisition was part of a long-term strategy by his company to diversify its business.